Moreover, de novo CNV analyses indicate an enrichment of genes of the PSD95 complex in schizophrenia[25], and rare exonic deletions implicate Gephyrin as a risk factor for autism, schizophrenia and seizures[26]. This evidence concerns the gene GPHN and schizophrenia.